![Meinrad Paul Gawaz](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Meinrad Paul Gawaz
Corporate Officer/Principal bij Eberhard Karls Universität Tübingen
Profiel
Meinrad Paul Gawaz is the founder of Corimmun GmbH, founded in 2006, and advanceCOR GmbH, founded in 2012.
He is currently the Head-Cardiology Department at Eberhard Karls Universität Tübingen.
Actieve functies van Meinrad Paul Gawaz
Bedrijven | Functie | Begin |
---|---|---|
Eberhard Karls Universität Tübingen | Corporate Officer/Principal | - |
Eerdere bekende functies van Meinrad Paul Gawaz
Bedrijven | Functie | Einde |
---|---|---|
advanceCOR GmbH
![]() advanceCOR GmbH Pharmaceuticals: MajorHealth Technology advanceCOR GmbH operates as a clinical drug developing company. The firm provides ELISA-based assay development on a fee-for-service basis, e. g. for the detection of drugs or other agents or for antibody detection in blood samples or other liquids. The company was founded by Roland Jahns, Dorothea Siegel-Axel, Martin Ungerer, Götz Münch, Martin Lohse, Roland Jahns, and Meinrad Paul Gawaz in June 2012 and is headquartered in Martinsried, Germany. | Oprichter | - |
Corimmun GmbH
![]() Corimmun GmbH BiotechnologyHealth Technology Corimmun GmbH operates as a biotechnology company which engages in the development of drugs. It specializes in peptides and biological drugs with focus on inflammatory mechanisms in heart failure and atherosclerosis. The company was founded by Martin Ungerer, Dorothea Siegel-Axel, Roland Jahns, Paul Gawaz Meinrad, Martin Lohse, and Götz Münch in 2006 and is headquartered in Neuss, Germany. | Oprichter | - |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Bedrijven in privébezit | 2 |
---|---|
Corimmun GmbH
![]() Corimmun GmbH BiotechnologyHealth Technology Corimmun GmbH operates as a biotechnology company which engages in the development of drugs. It specializes in peptides and biological drugs with focus on inflammatory mechanisms in heart failure and atherosclerosis. The company was founded by Martin Ungerer, Dorothea Siegel-Axel, Roland Jahns, Paul Gawaz Meinrad, Martin Lohse, and Götz Münch in 2006 and is headquartered in Neuss, Germany. | Health Technology |
advanceCOR GmbH
![]() advanceCOR GmbH Pharmaceuticals: MajorHealth Technology advanceCOR GmbH operates as a clinical drug developing company. The firm provides ELISA-based assay development on a fee-for-service basis, e. g. for the detection of drugs or other agents or for antibody detection in blood samples or other liquids. The company was founded by Roland Jahns, Dorothea Siegel-Axel, Martin Ungerer, Götz Münch, Martin Lohse, Roland Jahns, and Meinrad Paul Gawaz in June 2012 and is headquartered in Martinsried, Germany. | Health Technology |